Literature DB >> 22313121

Fetomaternal hemorrhage in normal vaginal delivery and in delivery by cesarean section.

Marek Lubusky1, Ondrej Simetka, Martina Studnickova, Martin Prochazka, Marta Ordeltova, Katherine Vomackova.   

Abstract

BACKGROUND: The objective was to determine the incidence and volume of fetomaternal hemorrhage (FMH) in normal vaginal delivery and in delivery by cesarean section. Determination of these variables would enable optimalization of guidelines for D alloimmunization prophylaxis. STUDY DESIGN AND METHODS: In a prospective cohort study, a total of 3457 examinations were performed, 2413 after normal vaginal delivery and 1044 after cesarean delivery. FMH was assessed by flow cytometry. (FMH is fetal red blood cell [RBC] volume; fetal blood volume is double [expected fetal hematocrit is 50%].)
RESULTS: The fetal RBC volume diagnosed in maternal circulation after delivery ranged from insignificant FMH of not more than 0.1 mL to excessive FMH of 65.9 mL (median, 0.7; mean, 0.78; SD, 1.48). FMH of more than 2.5 mL (immunoglobulin [Ig] G anti-D insufficient dose 50 µg) was observed in 1.4% (49/3457) and excessive volumes of FMH of more than 5 mL (insufficient dose, 100 µg) in 0.29% (10/3457). Delivery by cesarean section presented a higher risk of incidence of FMH of more than 2.5 mL (odds ratio, 2.2; p = 0.004) when compared with normal vaginal delivery. It did not, however, present a significant risk factor for the incidence of excessive volumes of FMH of more than 5 mL.
CONCLUSION: During normal vaginal delivery as well as during delivery by cesarean section, FMH of less than 5 mL occurs in the great majority of cases, and thus for the prevention of D alloimmunization, an IgG anti-D dose of 100 µg should be sufficient. Contrarily, only rarely does greater FMH occur and delivery by cesarean section does not present a risk factor.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2012        PMID: 22313121     DOI: 10.1111/j.1537-2995.2011.03536.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Mild-to-moderate foeto-maternal haemorrhage in the third trimester and at term of pregnancy: quantitative determination and clinical-diagnostic evaluation.

Authors:  Fausta Beneventi; Chiara Cavagnoli; Elena Locatelli; Silvia Bariselli; Margherita Simonetta; Gianluca Viarengo; Cesare Perotti; Arsenio Spinillo
Journal:  Blood Transfus       Date:  2017-04-19       Impact factor: 3.443

2.  Demographic and Behavioral Predictors of Severe Fetomaternal Hemorrhage: A Case-Control Study.

Authors:  Annemarie Stroustrup; Callie Plafkin; Thuy-An Tran; David A Savitz
Journal:  Neonatology       Date:  2016-02-10       Impact factor: 4.035

3.  Assessment of feto-maternal hemorrhage among rhesus D negative pregnant mothers using the kleihauer-betke test (KBT) and flow cytometry (FCM) in Addis Ababa, Ethiopia.

Authors:  Fekadu Urgessa; Aster Tsegaye; Yirgu Gebrehiwot; Asaye Birhanu
Journal:  BMC Pregnancy Childbirth       Date:  2014-11-07       Impact factor: 3.007

4.  Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study.

Authors:  Y M Slootweg; C Zwiers; J M Koelewijn; E van der Schoot; D Oepkes; I L van Kamp; M de Haas
Journal:  BJOG       Date:  2022-03-18       Impact factor: 7.331

5.  FIGO/ICM guidelines for preventing Rhesus disease: A call to action.

Authors:  Gerard H A Visser; Trude Thommesen; Gian Carlo Di Renzo; Anwar H Nassar; Steven L Spitalnik
Journal:  Int J Gynaecol Obstet       Date:  2021-01-09       Impact factor: 3.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.